Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling
Your provider will review medical history, current medications, allergies, endocrine concerns, metabolic risks, pregnancy or breastfeeding status, and contraindications before making any recommendation
All treatments require provider evaluation
If you see 5 doses instead of 5.2, this is intentional, to ensure accuracy
Brain tissue : May support neuronal regeneration, offering neuroprotective effects
US$ 28.96
.png)
US$ 28.11
US$ 28.33
US$ 22.11
